Meeting
2016 ASCO Annual Meeting
Prognostic value of the metastatic lymph node (N) ratio in the adjuvant chemoradiotherapy in stomach tumors (ARTIST) phase III trial
Authors
Soonil Lee
Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea
Soonil Lee , Se Hoon Park , Jeeyun Lee , Won Ki Kang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
NCT00323830
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4038)
DOI
10.1200/JCO.2016.34.15_suppl.4038
Abstract #
4038
Poster Bd #
30
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2).
First Author: Se Hoon Park
Poster
2015 ASCO Annual Meeting
Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study (GASTRIPEC).
First Author: Beate Rau
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).
First Author: Hiroyuki Arai
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).
First Author: Izuma Nakayama